Results 141 to 150 of about 9,490 (173)

Novel emerging reassortant H6 avian influenza viruses with internal genes from G57 genotype of H9N2 pose potential zoonotic risk. [PDF]

open access: yesEmerg Microbes Infect
Wan Z   +18 more
europepmc   +1 more source

Avian influenza virus H5N1 and H9N2 subtypes in different birds and humans: Findings from an extensive evaluation. [PDF]

open access: yesOpen Vet J
Rehman S   +10 more
europepmc   +1 more source

Identification of thermostability-enhancing mutations in H9N2 avian influenza virus hemagglutinin. [PDF]

open access: yesJ Virol
Liu B   +15 more
europepmc   +1 more source

Phylogenetic Analyses and Biological Characterization of H9N2 Avian Influenza Virus Isolated from Chickens in China from 2022 to 2023. [PDF]

open access: yesMicroorganisms
Song Y   +12 more
europepmc   +1 more source

The Function behind the Relation between Lipid Metabolism and Vimentin on H9N2 Subtype AIV Replication

open access: yesViruses, 2022
Avian influenza caused by H9N2 subtype avian influenza virus (AIV) poses a great threat to the healthy development of the poultry industry. Vimentin is closely related to intracellular lipid metabolism, which plays an important role during the viral ...
Xiu Li Feng, Guihu Yin, Xinmei Huang
exaly   +5 more sources

Preparation and Antigenic Site Identification of Monoclonal Antibodies against PB1 Protein of H9N2 Subtype AIV

open access: yesVeterinary Sciences
Recently, low pathogenic avian influenza virus (LPAIV), including H9N2 subtype, has been common clinical epidemic strains, and is widely distributed globally.
Xiu Li Feng, Guihu Yin, Jianing Hu
exaly   +5 more sources

In vivo inhibition of NAS preparation on H9N2 subtype AIV

open access: yesVirologica Sinica, 2010
NAS preparation, a kind of Chinese herbal medicine found by the Yunnan Eco-agricultural Research Institute, has potential antiviral activity. In this paper, the inhibiting effect of NAS preparation on H9N2 subtype Avian influenza virus (AIV) was investigated in vivo. Chickens infected with H9N2 virus were treated with NAS preparation for 4 days.
Jian-Ping Liang
exaly   +4 more sources

Home - About - Disclaimer - Privacy